Life & Health

Rising drug costs and opaque PBM practices are forcing employers to treat prescription benefits as enterprise risk.

As agencies embrace multi-line distribution, fragmented operational systems increasingly constrain their ability to scale and deliver integrated value.

Continuous monitoring and early screening are exposing insurers to costs before traditional coverage activates.

Pre-payment claim evaluation led by human experts is redefining risk management as healthcare complexity and costs escalate.

Despite clear evidence, most health plans fail to operationalize nutrition as a clinical intervention for their highest-cost members.

Life insurers are advancing from AI experimentation to execution, prioritizing ecosystem integration to address escalating retirement security demands.

Life settlement sellers rarely receive competing offers, leaving billions on the table while direct buyers capture the spread.

Insurers are achieving 30% efficiency gains as AI shifts actuarial work from production tasks to interpretation and governance.